Joseph P. Hagan - 18 May 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Joseph P. Hagan
Issuer symbol
AUPH
Transactions as of
18 May 2023
Net transactions value
-$2,878
Form type
4
Filing time
23 May 2023, 17:18:43 UTC
Previous filing
17 Jan 2023
Next filing
14 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AUPH Common Stock Options Exercise +8,733 +250% 12,233 18 May 2023 Direct F1
transaction AUPH Common Stock Sale $2,878 -272 -2.2% $10.58 11,961 19 May 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Options Exercise $0 -8,733 -100% $0.000000* 0 18 May 2023 Common Stock 8,733 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of Issuer Common Stock. The RSUs have no expiration date.
F2 Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs.